Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quidel

This article was originally published in The Gray Sheet

Executive Summary

Files 510(k) application for its QuickVue one-step fecal occult blood test. Quidel maintains that the two-minute test has "improved specificity and sensitivity over the most widely used tests which employ guaiac-based chemistry." Accuracy of guaiac-based tests is affected by patient noncompliance with dietary restrictions that must be followed for two days prior to testing. "The QuickVue FOB test circumvents the dietary restrictions and compliance problems...because it is very specific for human hemoglobin found only in human red blood cells," Quidel says.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000238

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel